News Guest User 14/12/23 Guest User 14/12/23 Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction Read More Guest User 17/11/23 Guest User 17/11/23 Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry Read More Guest User 16/10/23 Guest User 16/10/23 Infensa CSO and co-founder Professor Glenn King received the Prime Minster’s Prize for Innovation, the highest honour for science translation in Australia Read More
Guest User 14/12/23 Guest User 14/12/23 Infensa scientists publish in European Heart Journal showing efficacy of lead drug candidate when administered at relevant timepoints in preclinical models of moderate and severe myocardial infarction Read More
Guest User 17/11/23 Guest User 17/11/23 Infensa CEO Mark Smythe received the LSQ McCullough Robertson Industry Excellence Award from Life Sciences Queensland in recognition of his major contributions to the Queensland life sciences industry Read More
Guest User 16/10/23 Guest User 16/10/23 Infensa CSO and co-founder Professor Glenn King received the Prime Minster’s Prize for Innovation, the highest honour for science translation in Australia Read More
